Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousBone MarrowTransplantation, AutologousHematopoietic Stem Cell TransplantationBone Marrow CellsGraft vs Host DiseaseHematopoietic Stem Cell MobilizationTransplantation ConditioningWhole-Body IrradiationHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorBlood PlateletsGraft SurvivalBusulfanAnemia, AplasticCyclophosphamideTransplantation ChimeraLeukemiaLeukapheresisBone and BonesTissue DonorsHematologic NeoplasmsPlatelet AggregationCombined Modality TherapyPlatelet CountBone Marrow PurgingAntigens, CD34Histocompatibility TestingHistocompatibilityLiver TransplantationHematopoiesisBlood Component RemovalRecurrenceTreatment OutcomeTransplantation, IsogeneicBone Marrow DiseasesStem CellsMelphalanStem Cell TransplantationLymphoma, Non-HodgkinRemission InductionTime FactorsAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcuteImmunosuppressive AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood CellsMultiple MyelomaMice, Inbred C57BLBlood Cell CountT-LymphocytesKidney TransplantationEtoposidePlatelet TransfusionPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionLeukocyte TransfusionCord Blood Stem Cell TransplantationColony-Forming Units AssayRetrospective StudiesFlow CytometryLeukocyte CountAcute DiseaseTransplantation ImmunologyLeukemia, MyeloidRadiation ChimeraSurvival AnalysisImmunosuppressionBone Marrow ExaminationMyelodysplastic SyndromesCytarabineHematologic DiseasesHLA AntigensGraft RejectionHepatic Veno-Occlusive DiseaseDisease-Free SurvivalSurvival RateCells, CulturedCyclosporineLeukocytes, MononuclearBone RemodelingPlatelet AdhesivenessCarmustineImmunophenotypingNuclear FamilyBone Marrow NeoplasmsInfectionLymphocyte TransfusionLymphomaCell SeparationCytomegalovirus InfectionsFollow-Up StudiesGraft vs Host ReactionHodgkin DiseaseThiotepaChimeraMyeloablative AgonistsGraft vs Leukemia Effect